de Paz David, Diez Julio, Ariza Fredy, Scarpetta Diego Fernando, Quintero Jaime A, Carvajal Sandra Milena
Department of Emergency Service, Fundación Valle del Lili, Cali, 760032, Colombia.
Anesthesia and Perioperative Medicine, Fundación Valle del Lili, Cali 760032, Colombia.
Open Access Emerg Med. 2021 Feb 22;13:67-73. doi: 10.2147/OAEM.S275767. eCollection 2021.
Cardiac arrest (CA) is one of the leading causes of death worldwide. Among patients with CA, pulmonary embolism (PE) accounts for approximately 10% of all cases.
To compare the outcomes after cardiopulmonary-cerebral resuscitation (CCPR) with and without thrombolytic therapy (TT) in patients with CA secondary to PE.
We included patients older than 17 years admitted to our hospital between 2013 and 2017 with a diagnosis of CA with confirmed or highly suspected PE who received CCPR with or without TT. Measures of central tendency were used to depict the data.
The study comprised 16 patients, 8 of whom received CCPR and thrombolysis with alteplase, whereas the remaining patients received CCPR without TT. The most frequent rhythm of CA in both groups was pulseless electrical activity. Return of spontaneous circulation (ROSC) occurred in 100% of patients who received TT and in 88% of non-thrombolysed patients. The mortality rate of patients who received TT and non-thrombolysed patients at 24 hours was 25% and 50%, respectively. However, at the time of hospital discharge, the mortality was the same in both groups (62%). In patients who received TT, mortality was related to sepsis and hemorrhage whereas in non-thrombolysed patients, mortality was due to myocardial dysfunction.
Intra-arrest thrombolysis resulted in a higher likelihood of ROSC and a higher 24-hour survival in adults with CA secondary to acute PE. Overall, the survival at hospital discharge was the same in the two groups.
心脏骤停(CA)是全球主要死因之一。在心脏骤停患者中,肺栓塞(PE)约占所有病例的10%。
比较心肺脑复苏(CCPR)联合与不联合溶栓治疗(TT)对肺栓塞继发心脏骤停患者的治疗效果。
纳入2013年至2017年间我院收治的17岁以上诊断为心脏骤停且确诊或高度怀疑肺栓塞并接受CCPR联合或不联合TT治疗的患者。采用集中趋势测量来描述数据。
该研究共纳入16例患者,其中8例接受了CCPR联合阿替普酶溶栓治疗,其余患者接受了不联合TT的CCPR治疗。两组中最常见的心脏骤停节律是无脉电活动。接受TT治疗的患者自主循环恢复(ROSC)率为100%,未接受溶栓治疗的患者为88%。接受TT治疗的患者和未接受溶栓治疗的患者在24小时时的死亡率分别为25%和50%。然而,在出院时,两组的死亡率相同(62%)。接受TT治疗的患者死亡率与脓毒症和出血有关,而未接受溶栓治疗的患者死亡率则是由于心肌功能障碍。
对于急性肺栓塞继发心脏骤停的成人患者,在心脏骤停期间进行溶栓治疗可提高ROSC的可能性和24小时生存率。总体而言,两组出院时的生存率相同。